Reactive Oxygen Species (ROS), Troublemakers between Nuclear Factor-κB (NF-κB) and c-Jun NH2-terminal Kinase (JNK)

Cancer Research

Volumn 64, Issue 6, 2004, Pages 1902-1905

  Zhang, Yadong ^a   Chen, Fei ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CYTOKINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS;

ALLELE; APOPTOSIS; CARCINOGENESIS; CYP1B1 GENE; GENE; GENE DISRUPTION; GENETIC DISORDER; IKK KINASE DOMAIN; IKKB GENE; KNOCKOUT GENE; OXIDATIVE STRESS; P450 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; RELA GENE; REVIEW; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION INITIATION;

ANIMALS; HUMANS; I-KAPPA B KINASE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES;

EID: 1542405935     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3361     Document Type: Review

References (64)

1. Karin M, Delhase M. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA 1998;95:9067-9.
2. Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 2002;22:7158-67.
3. Li X, Commane M, Jiang Z, Stark GR. IL-1-induced NF-κB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci USA 2001;98:4461-5.
4. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IκB α kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997;88:213-22.
5. Moscat J, Diaz-Meco MT, Rennert P. NF-κB activation by protein kinase C isoforms and B-cell function. EMBO Rep 2003;4:31-6.
6. Castrillo A, Traves PG, Martin-Sanz P, Parkinson S, Parker PJ, Bosca L. Potentiation of protein kinase Cζ activity by 15-deoxy-8(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-κB that promotes apoptosis in macrophages. Mol Cell Biol 2003;23:1196-208.
7. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol 2002;270:47-61.
8. Li X, Commane M, Nie H, et al. Act1, an NF-κB-activating protein. Proc Natl Acad Sci USA 2000;97:10489-93.
9. Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U. CIKS, a connection to IκB kinase and stress-activated protein kinase. Proc Natl Acad Sci USA 2000;97:10494-9.
10. Xia Y, Makris C, Su B, et al. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci USA 2000;97:5243-8.
11. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol Cell 1998;1:543-51.
12. Kasibhatla S, Genestier L, Green DR. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via NF-κB. J Biol Chem 1999;274:987-92.
13. Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science (Wash DC) 1997;275:200-3.
14. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 1997;7:703-13.
15. Deak JC, Cross JV, Lewis M, et al. Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. Proc Natl Acad Sci USA 1998;95:5595-600.
16. Spiegelman VS, Stavropoulos P, Latres E, et al. Induction of β-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-κB. J Biol Chem 2001;276:27152-8.
17. Read MA, Whitley MZ, Gupta S, et al. Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 1997;272:2753-61.
18. Kanakaraj P, Schafer PH, Cavender DE, et al. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J Exp Med 1998;187:2073-9.
19. Chen F, Lu Y, Zhang Z, et al. Opposite effect of NF-κB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 2001;276:11414-9.
20. Javelaud D, Besancon F. NF-κB activation results in rapid inactivation of JNK in TNF α-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-κB. Oncogene 2001;20:4365-72.
21. Garcia-Cao I, Lafuente MJ, Criado LM, Diaz-Meco MT, Serrano M, Moscat J. Genetic inactivation of Par4 results in hyperactivation of NF-κB and impairment of JNK and p38. EMBO Rep 2003;4:307-12.
22. Tang G, Minemoto Y, Dibling B, et al. Inhibition of JNK activation through NF-κB target genes. [comment]. Nature (Lond) 2001;414:313-7.
23. De Smaele E, Zazzeroni F, Papa S, et al. Induction of gadd45β by NF-κB down-regulates pro-apoptotic JNK signalling. Nature (Lond) 2001;414:308-13.
24. Takekawa M, Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 1998;95:521-30.
25. Suzuki Y, Nakabayashi Y, Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 2001;98:8662-7.
26. Amanullah A, Azam N, Balliet A, et al. Cell signalling (communication arising): Cell survival and a Gadd45-factor deficiency. Nature (Lond) 2003;424:741.
27. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. Characterization of XIAP-deficient mice. Mol Cell Biol 2001;21:3604-8.
28. Sanna MG, da Silva Correia J, Luo Y, et al. ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis. J Biol Chem 2002;277:30454-62.
29. Lu B, Ferrandino AF, Flavell RA. Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nat Immunol 2004;5:38-44.
30. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
31. van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-κB as a potential biomarker for oxidative stress. Br J Nutr 2001;86 Suppl 1:S121-7.
32. Schreck R, Albermann K, Baeuerle PA. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun 1992;17:221-37.
33. Bowie, A, O'Neill, LA. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries Biochem Pharmacol 2000;59:13-23.
34. Li N, Karjn M. Is NF-κB the sensor of oxidative stress? FASEB J 1999;13:1137-43.
35. Karin M, Takahashi T, Kapahi P, et al. Oxidative stress and gene expression: the AP-1 and NF-κB connections. Biofactors 2001;15:87-9.
36. Hayakawa M, Miyashita H, Sakamoto I, et al. Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J 2003;22:3356-66.
37. Nishi T, Shimizu N, Hiramoto M, et al. Spatial redox regulation of a critical cysteine residue of NF-κB in vivo. J Biol Chem 2002;277:44548-56.
38. Molitor JA, Ballard DW, Greene WC. κB-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation. New Biol 1991;3:987-96.
39. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature (Lond) 2000;403:103-8.
40. Chen F, Shi X. Signaling from toxic metals to NF-κB and beyond: not just a matter of reactive oxygen species. Environ Health Perspect 2002;110 Suppl 5:807-11.
41. Kapahi P, Takahashi T, Natoli G, et al. Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase. J Biol Chem 2000;275:36062-6.
42. Kom SH, Wouters EF, Vos N, Janssen-Heininger YM. Cytokine-induced activation of nuclear factor-κB is inhibited by hydrogen peroxide through oxidative inactivation of IκB kinase. J Biol Chem 2001;276:35693-700.
43. Chen YR, Shrivastava A, Tan TH. Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene 2001;20:367-74.
44. Bernardini S, Bernassola F, Cortese C, et al. Modulation of GST PI-1 activity by polymerization during apoptosis. J Cell Biochem 2000;77:645-53.
45. Sakon S, Xue X, Takekawa M, et al. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 2003;22:3898-909.
46. Chen F, Castranova V, Li Z, Karin M, Shi X. Inhibitor of nuclear factor κB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic. Cancer Res 2003;63:7689-93.
47. Sapone A, Affatato A, Canistro D, et al. Induction and suppression of cytochrome P450 isoenzymes and generation of oxygen radicals by procymidone in liver, kidney and lung of CD1 mice. Mutat Res 2003;527:67-80.
48. Guengerich FP. Cytochrome P450 enzymes in the generation of commercial products. Nat Rev Drug Discov 2002;1:359-66.
49. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature (Lond) 2000;408:239-47.
50. Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA. An receptor and NF-κB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 1999;274:510-5.
51. Ke S, Rabson AB, Germino JF, Gallo MA, Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-α and lipopolysaccharide. J Biol Chem 2001;276:39638-44.
52. Whitelaw ML, McGuire J, Picard D, Gustafsson JA, Poellinger L. Heat shock protein hsp90 regulates dioxin receptor function in vivo. Proc Natl Acad Sci USA 1995;92:4437-41.
53. Zhang L, Savas U, Alexander DL, Jefcoate CR. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression. J Biol Chem. 1998;273:5174-83.
54. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Wash DC) 1996;274:784-7.
55. Wang CY, Mayo MW, Komeluk RG, Goeddel DV, Baldwin AS Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Wash DC) 1998;281:1680-3.
56. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFα-induced apoptosis. Cell 2003;115:61-70.
57. Reuther-Madrid JY, Kashatus D, Chen S, et al. The p65/RelA subunit of NF-κB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol. 2002;22:8175-83.
58. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell 2003;11:1479-89.
59. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999;22:667-76.
60. Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 1999;89:115-24.
61. Zhang JY, Green CL, Tao S, Khavari PA. NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 2004;18:17-22.
62. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Investig. 2001;107:241-6.
63. Jefcoate CR, Liehr JG, Santen RJ, et al. Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl. Cancer Inst (Monogr) 2000;27:95-112.
64. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-10.